Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apremilast + Topicals in Plaque Psoriasis
NCT03930186Phase 3Completed
- Sponsor
- Amgen
- Start
- Jun 2019
- Primary completion
- May 2020
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of apremilast in plaque psoriasis, sponsored by Amgen. Started Jun 2019; status: completed.
02
Drugs
apremilast
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT03930186.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03930186.